Functional and metabolic characteristics of peripheral blood mononuclear phagocytes in patients with different clinical courses of multiple sclerosis

  • O. M. Koliada Kharkiv National Medical University
  • N. I. Vdovichenko Mechnikov Institute of Microbiology and Immunology
  • T. I. Kolyada Mechnikov Institute of Microbiology and Immunology
  • O. P. Bilozorov Mechnikov Institute of Microbiology and Immunology
Keywords: demyelinating disease; expression of cosignal molecules; L-arginine metabolism; stimulation of Toll-like receptors

Abstract

Functional and metabolic features of intact and stimulated mononuclear phagocytes were studied in patients with different clinical courses of multiple sclerosis, the study included 66 patients with relapsing-remitting and 32 patients with progressive course of multiple sclerosis. The state of the mononuclear phagocytes was characterized by expression of costimulatory molecules and direction of L-arginine metabolism. Relative quantities of CD80, CD86 and PD-L1 positive monocytes were determined with Phycoerytrin-labeled monoclonal antibodies in immunofluorescence test in peripheral blood and after culture in parallel series with addition of: (a) E.coli lipopolysaccharide (a stimulator of TLR4), (b) a single-stranded RNA – preparation ssRNA40/LyoVec (a stimulator of TLR7/8), (c) IL-4 (an anti-inflammatory interleukin). The formation of NO was determined by the amount of nitrite in the culture supernatants, arginase activity was determined in cell lysates of the monocyte fraction. We showed that functional and phenotypic characteristics of monocytes depend on the clinical course of multiple sclerosis. In patients with progressive course, the relative number of CD86+ cells was significantly higher and PD-L1+ cells significantly lower than in patients with relapsing-remitting course and healthy persons, in patients with relapsing-remitting course the number of PD-L1+ cells was increased. The number of CD80+ cells did not show any significant difference in the investigated groups of patients relative to the control group. In vitro stimulation of peripheral blood monocytes with TLR4/8 produced a significant increase in the number of CD86+ and decrease in the number of PD-L1+ cells in patients with the progressive course. In patients with the relapsing-remitting course LPS produced an increase in number of PD-L1+ cells. We did not find any difference in activity of the arginase pathway of L-arginine metabolism in the intact monocyte fraction of peripheral blood in patients with multiple sclerosis versus the control group, but stimulation with TLR4 agonist of mononuclear cells of patients with progressive course caused significant increased arginase activity versus baseline. At the same time, versus control cells arginase activity in patients with the progressive course decreased after LPS treatment, but trended to increase after TLR7/8 treatment. In patients with the relapsing-remitting course these changes had a similar direction but were less expressed. The results may be considered as an indication of the activation of peripheral blood monocytes and their polarization trend in the M1 direction in patients with the progressive course of multiple sclerosis, these changes could be considered as signs of violation of autoimmune regulatory mechanisms in multiple sclerosis.

References

Adiele, R. C., & Adiele, C. A. (2019). Metabolic defects in multiple sclerosis. Mitochondrion, 44, 7–14.

Babu, S., Kumaraswami, V., & Nutman, T. B. (2009). Alternatively activated and immunoregulatory monocytes in human filarial infections. The Journal of Infectious Diseases, 199(12), 1827–1837.

Baufeld, C., O’Loughlin, E., Calcagno, N., Madore, C., & Butovsky, O. (2018). Differential contribution of microglia and monocytes in neurodegenerative diseases. Journal of Neural Transmission, 125(5), 809–826.

Bogdan, C. (2015). Nitric oxide synthase in innate and adaptive immunity: An update. Trends in Immunology, 36(3), 161–178.

Bogie, J. F., Stinissen, P., & Hendriks, J. J. (2014). Macrophage subsets and microglia in multiple sclerosis. Acta Neuropathologica, 128(2), 191–213.

Christophi, G. P., Panos, M., Hudson, C. A., Christophi, R. L., Gruber, R. C., Mersich, A. T., Blystone, S. D., Jubelt, B., & Massa, P. T. (2009). Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Laboratory Investigation, 89(7), 742–759.

Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010). The PD-1 pathway in tolerance and autoimmunity. Immunological Reviews, 236, 219–242.

Herzmann, N., Salamon, A., Fiedler, T., & Peters, K. (2017). Lipopolysaccharide induces proliferation and osteogenic differentiation of adipose-derived mesenchymal stromal cells in vitro via TLR4 activation. Experimental Cell Research, 350(1), 115–122.

Italiani, P., & Boraschi, D. (2014). From monocytes to M1/M2 macrophages: Phenotypical vs. functional differentiation. Frontiers in Immunology, 5, 514.

Lan, M., Tang, X., Zhang, J., & Yao, Z. (2018). Insights in pathogenesis of multiple sclerosis: Nitric oxide may induce mitochondrial dysfunction of oligodendrocytes. Reviews in the Neurosciences, 29(1), 39–53.

Lester, S. N., & Li, K. (2014). Toll-like receptors in antiviral innate immunity. Journal of Molecular Biology, 426(6), 1246–1264.

Ljubisavljevic, S., Stojanovic, I., Pavlovic, R., Sokolovic, D., Pavlovic, D., Cvetkovic, T., & Stevanovic, I. (2012). Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis. Journal of the Neurological Sciences, 318, 106–111.

Lubina-Dąbrowska, N., Stepień, A., Sulkowski, G., Dąbrowska-Bouta, B., Langfort, J., & Chalimoniuk, M. (2017). Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis. Archivum Immunologiae et Therapiae Experimentalis, 65(4), 325–338.

Mammana, S., Fagone, P., Cavalli, E., Basile, M. S., Petralia, M. C., Nicoletti, F., Bramanti, P., & Mazzon, E. (2018). The role of macrophages in neuroinflammatory and neurodegenerative pathways of Alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets. International Journal of Molecular Sciences, 19(3), 831.

Mattila, J. T., Ojo, O. O., Kepka-Lenhart, D., Marino, S., Kim, J. H., Eum, S. Y., Via, L. E., Barry, C. E. 3rd, Klein, E., Kirschner, D. E., Morris, S. M. Jr, Lin, P. L., & Flynn, J. L. (2013). Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. Journal of Immunology, 191(2), 773–784.

Munder, M., Mollinedo, F., Calafat, J., Canchado, J., Gil-Lamaignere, C., Fuentes, J. M., Luckner, C., Doschko, G., Soler, G., Eichmann, K., Müller, F. M., Ho, A. D., Goerner, M., & Modolell, M. (2005). Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood, 105(6), 2549–2556.

Murray, P. J. (2017). Macrophage polarization. Annual Review of Physiology, 79, 541–566.

Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., Locati, M., Mantovani, A., Martinez, F. O., Mege, J. L., Mosser, D. M., Natoli, G., Saeij, J. P., Schultze, J. L., Shirey, K. A., Sica, A., & Wynn, T. A. (2014). Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity, 41(1), 14–20.

Nahrendorf, M., & Swirski, F. K. (2016). Abandoning M1/M2 for a network model of macrophage function. Circulation Research, 119(3), 414–417.

Okabe, Y., & Medzhitov, R. (2016). Tissue biology perspective on macrophages. Nature Immunology, 17(1), 9–17.

Okada, K., Kobata, M., Sennari, Y., Iwanaka, Y., Hashimoto, T., Ohnari, K., & Tahara, M. (2017). Levels of nitric oxide metabolites in cerebrospinal fluid correlate with cognitive impairment in early stage multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 88(10), 892–893.

O'Loughlin, E., Madore, C., Lassmann, H., & Butovsky, O. (2018). Microglial phenotypes and functions in multiple sclerosis. Cold Spring Harbor Perspectives in Medicine, 8(2), a028993.

Rath, M., Müller, I., Kropf, P., Closs, E. I., & Munder, M. (2014). Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages. Frontiers in Immunology, 5, 532.

Ravasi, T., Wells, C. A., & Hume, D. A. (2007). Systems biology of transcription control in macrophages. BioEssays, 29(12), 1215–1226.

Reiner, N. E. (2009). Methods in molecular biology. Macrophages and dendritic cells. Methods and protocols. Preface. Methods in Molecular Biology, 531, v–vi.

Repnik, U., Knezevic, M., & Jeras, M. (2003). Simple and cost-effective isolation of monocytes from buffy coats. Journal of Immunological Methods, 278, 283–292.

Rodriguez, P. C., Ochoa, A. C., & Al-Khami, A. A. (2017). Arginine metabolism in myeloid cells shapes innate and adaptive immunity. Frontiers in Immunology, 8, 93.

Schreiner, B., Mitsdoerffer, M., Kieseier, B. C., Chen, L., Hartung, H. P., Weller, M., & Wiendl, H. (2004). Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: Relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology, 155, 172–182.

Shin, W., Berkowitz, D. E., & Ryoo, S. (2012). Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice. Expimental and Molecular Medicine, 44, 594–602.

Sica, A., Erreni, M., Allavena, P., & Porta, C. (2015). Macrophage polarization in pathology. Cellular and Molecular Life Sciences, 72(21), 4111–4126.

Thomas, A. C., & Mattila, J. T. (2014). "Of mice and men": Arginine metabolism in macrophages. Frontiers in Immunology, 5, 479.

Tupotilov, O. V., & Kolyada, T. I. (2018). Citokіnogenez pri TLR-oposeredkovanyj aktyvacіji monocytіv peryferychnoji krovі u hvoryh z rozsіjanym sklerozom [Cytokinogenesis by TLR-induced activation of peripheral blood monocytes in patients with multiple sclerosis]. Vіsnyk Problem Bіologіji і Medycyny, 145, 181–185 (in Ukrainian).

Vdovichenko, N., Kolіada, О., & Tupotilov, O. (2020). Osoblyvosti tsytokinovoho profiliu v patsyentiv z riznymy typamy perebihu rozsijanoho sklerozu [Features of cytokine profile in patients with different types of multiple sclerosis]. Immunology and Allergology: Science and Practice, 1, 12–16 (in Ukrainian).

Wiesemann, E., Deb, M., Trebst, C., Hemmer, B., Stangel, M., & Windhagen, A. (2008). Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis. Multiple Sclerosis, 14(2), 166–176.

Xie, Z. X., Zhang, H. L., Wu, X. J., Zhu, J., Ma, D. H., & Jin, T. (2015). Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis. Mediators of Inflammation, 2015, 513295.

Published
2020-11-15
How to Cite
Koliada, O. M., Vdovichenko, N. I., Kolyada, T. I., & Bilozorov, O. P. (2020). Functional and metabolic characteristics of peripheral blood mononuclear phagocytes in patients with different clinical courses of multiple sclerosis . Regulatory Mechanisms in Biosystems, 11(4), 494-500. https://doi.org/10.15421/022075